New therapeutic approach for Duchenne muscular dystrophy combines LED therapy with idebenone

FHS
June 14, 2024
3:42 pm

In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an antioxidant compound investigated for application in neurodegenerative diseases.

Digital transformation of the supply chain will make data more valuable – are you prepared? – Pharmaceutical Technology

Share this article Data holds the key to helping modern pharma firms excel. Credit: Gorodenkoff/Shutterstock It has been a long decade for the pharmaceutical industry.

February 24, 2024

Sickle cell patients lag behind in COVID vaccination despite higher risks

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new

January 10, 2024

Neoadjuvant PD-1 Blockade Boosts pCR Rates in Early Esophageal Cancer

SAN FRANCISCO — Adding an investigational PD-1 inhibitor to chemotherapy in the neoadjuvant setting significantly improved pathological complete response (pCR) rates for patients with resectable

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.